Purified amniotic membrane compositions and methods of use
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
1. A ground or pulverized amniotic membrane derived from frozen or previously frozen placental material.
2. The ground or pulverized amniotic membrane of claim 1 , wherein the ground or pulverized amniotic membrane is in the form of a homogenate.
3. The ground or pulverized amniotic membrane of claim 1 , wherein the ground or pulverized amniotic membrane is in the form of a dry powder, liquid or suspension.
4. The ground or pulverized amniotic membrane of claim 1 , wherein the placental material is placenta.
5. The ground or pulverized amniotic membrane of claim 1 , wherein the amniotic membrane is human amniotic membrane, bovine amniotic membrane, or porcine amniotic membrane.
6. A composition comprising ground or pulverized amniotic membrane derived from frozen or previously frozen placental material.
7. The composition of claim 6 , wherein the placental material is placenta.
8. The composition of claim 6 , further comprising a pharmaceutically-acceptable excipient.
9. The composition of claim 6 , as a non-solid dosage form.
10. The composition of claim 9 , as a solution, suspension, paste, ointment, oil, emulsion, cream, lotion, gel, patch, stick, balm, or shampoo.
11. The composition of claim 6 , as an ophthalmic composition.
12. The composition of claim 6 , as a topical composition.
13. A wound dressing comprising ground or pulverized amniotic membrane derived from frozen or previously frozen placental material.
14. The wound dressing of claim 13 , wherein the placental material is placenta.